Interestingly, we found that there is a novel tumor suppressive RXRα-KRT7-AS-PTEN singling axis in cancer cells, and activation of the RXRα-KRT7-AS-PTEN axis is a novel strategy for developing new therapeutics against cancer. This evidence concerns the gene KRT7 and cancer.